Patents by Inventor Eric Dausse

Eric Dausse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9902961
    Abstract: The invention relates to an aptamer that has a G-quadruplex structure and is able to inhibit the enzymatic activity of the MMP-9 protein, as well as to the dermatological and cosmetic uses thereof.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: February 27, 2018
    Assignees: LVMH Recherche, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Eric Dausse, Jean-Jacques Toulme, Jean Hubert Cauchard, Robin Kurfurst, Sylvianne Schnebert
  • Patent number: 9732348
    Abstract: The invention relates to a DNA aptamer that can inhibit the enzymatic activity of tyrosinase for the conversion of tyrosine into L-DOPA and dopaquinone, and to the dermatological and cosmetic uses thereof.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: August 15, 2017
    Assignees: L V M H Recherché, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jean Hubert Cauchard, Robin Kurfurst, Sylvianne Schnebert, Eric Dausse, Jean-Jacques Toulme
  • Publication number: 20160326530
    Abstract: The invention relates to an aptamer that has a G-quadruplex structure and is able to inhibit the enzymatic activity of the MMP-9 protein, as well as to the dermatological and cosmetic uses thereof.
    Type: Application
    Filed: December 30, 2014
    Publication date: November 10, 2016
    Applicants: L V M H Recherche, Institut National De La Santé Et De La Recherche Médicale (INSERM)
    Inventors: Eric Dausse, Jean-Jacques Toulme, Jean Hubert Cauchard, Robin Kurfurst, Sylvianne Schnebert
  • Publication number: 20160274095
    Abstract: The present invention relates to a kit-of-parts comprising at least one nucleic acid molecule NA1 and at least one nucleic acid molecule NA2 wherein the nucleic acid molecules NA1 and NA2 are capable of forming duplexes via the formation of a kissing complex. The present invention also describes use of such kit-of-parts for detecting target molecules of interest but also for selecting aptamers of interest in solution.
    Type: Application
    Filed: November 13, 2014
    Publication date: September 22, 2016
    Inventors: Jean-Jacques Toulme, Eric Dausse, Guillaume Durand, Eric Peyrin, Corinne Ravelet
  • Publication number: 20150337308
    Abstract: The present invention relates to a nucleic acid aptamer that binds specifically to human matrix metalloproteinase 9 (h MMP-9) and its use for imaging h MMP-9 in a subject in need thereof.
    Type: Application
    Filed: April 11, 2013
    Publication date: November 26, 2015
    Applicant: CHU DE BORDEAUX
    Inventors: Jean-Jacques Toulme, Sonia Da Rocha, Eric Dausse, Michele Allard, Laurent Azema
  • Publication number: 20150329863
    Abstract: The invention relates to a DNA aptamer that can inhibit the enzymatic activity of tyrosinase for the conversion of tyrosine into L-DOPA and dopaquinone, and to the dermatological and cosmetic uses thereof.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 19, 2015
    Inventors: Jean Hubert CAUCHARD, Robin KURFURST, Sylvianne SCHNEBERT, Eric DAUSSE, Jean-Jacques TOULME
  • Publication number: 20120295811
    Abstract: The present invention relates to nucleic acids that bind specifically to the matrix protein-1 of type A influenza viruses and uses thereof for detecting such viruses in a sample of interest.
    Type: Application
    Filed: November 23, 2010
    Publication date: November 22, 2012
    Inventors: Jean-Jacques Toulme, Eric Dausse, Francois Cornet, Daniel Desmecht